SCHEMBL19645664

SCHEMBL19645664

Fc1c(CCSS)cccc1OC(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPL P40238 1/20 0.40
▸ KDM2B Q8NHM5 1/20 0.36
▸ PHF8 Q9UPP1 1/20 0.36
▸ SLC6A3 Q01959 7/20 0.34
▸ SLC6A2 P23975 6/20 0.34
▸ SLC6A4 P31645 5/20 0.34
▸ KCNH2 Q12809 4/20 0.34
▸ CYP2D6 P10635 3/20 0.34
▸ DRD2 P14416 4/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ GRIN2B Q13224 2/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ P2RX7 Q99572 1/20 0.31
▸ MPO P05164 1/20 0.31
▸ HTR2A P28223 2/20 0.31
▸ HTR2C P28335 2/20 0.31
▸ C5AR1 P21730 1/20 0.31
▸ HTR2B P41595 1/20 0.30
▸ HDAC3 O15379 1/20 0.30
▸ HDAC1 Q13547 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20307141 0.82 MPL (0.39) MPLKDM2BPHF8SLC6A3SLC6A2
SCHEMBL30580173 0.76 MPL (0.45) MPLKDM2BPHF8SLC6A3SLC6A2
SCHEMBL4550818 0.76 MPL (0.45) MPLKDM2BPHF8SLC6A3SLC6A2
SCHEMBL28952591 0.75 MPL (0.41) MPLKDM2BPHF8SLC6A3SLC6A2
SCHEMBL29875817 0.75 MPL (0.41) MPLKDM2BPHF8SLC6A3SLC6A2
SCHEMBL2716488 0.75 MPL (0.41) MPLKDM2BPHF8SLC6A3SLC6A2
SCHEMBL17053066 0.75 GABRA1 (0.42) MPLKDM2BPHF8SLC6A3SLC6A2
SCHEMBL2713811 0.75 MPL (0.41) MPLKDM2BPHF8SLC6A3SLC6A2
Hydrochloric Acid SCHEMBL2715685 0.75 MPL (0.44) MPLKDM2BPHF8SLC6A3SLC6A2
SCHEMBL22792332 0.74 ALOX5 (0.48) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828396-B2 Alkyne compounds for treatment of complement mediated disorders ACHILLION PHARMACEUTICALS, INC. (US) 2017-11-28 — — US disclosed
Send feedback